India Condom Market to Reach USD 417 Million by 2032, Growing at a CAGR of 8.19% During 2026–2032


The India condom market was valued at an estimated USD 239 million in 2025 and is projected to grow from approximately USD 260 million in 2026 to nearly USD 417 million by 2032, registering a CAGR of 8.19% during 2026–2032. Growth is supported by commercial demand, institutional procurement, increasing contraceptive acceptance, wider reproductive-health engagement, and improving access through established physical retail and expanding digital channels.

Additionally, broader reproductive-health awareness is expanding the addressable consumer base by emphasizing informed choice, preventive protection, and shared responsibility. A 2025 UNFPA assessment identified wider contraceptive choice, access for young and marginalized populations, behavior-change communication, and engagement of men and boys as priorities. During 2025, its life-skills education reached 6.4 million adolescents, while digital campaigns reached more than 47.7 million people.

Furthermore, participatory digital campaigns are moving brand engagement beyond conventional advertising and product-led messaging. During 2025, Durex India used issue-based initiatives addressing online harassment, women’s self-examination, and private social-media interactions, while Manforce introduced an AI-generated brand ambassador through an online competition decided by public voting. Consequently, technology-enabled storytelling is supporting brand recall and more acceptable conversations around intimacy, protection, and women’s well-being.

From a segmentation perspective, offline commercial retail led the route to market with an estimated 55% market share in 2026, supported by neighborhood access, established replenishment networks, and immediate availability across pharmacies, general trade, convenience stores, and modern retail. Meanwhile, male/external condoms accounted for approximately 98% by product type, reflecting familiarity, lower unit prices, straightforward usage, broad availability, and extensive differentiation through flavors, textures, thinness, and lubrication.

Supported by increasing consumption, differentiated product formats, commercial and institutional demand, and wider e-commerce and quick-commerce access, the market is expected to sustain strong expansion through 2032. However, social stigma, rural price sensitivity, uneven retail availability, and volatility in latex, petroleum-linked chemicals, packaging materials, and exchange rates will continue shaping adoption, pricing, and supplier margins, further states the research report, “India Condom Market Analysis, 2026.”

India Condom Market Highlights

  • The India Condom Market was valued at approximately USD 239 million in 2025 and is projected to grow from USD 260 million in 2026 to USD 417 million by 2032.
  • The market is expected to register a CAGR of 8.19% during 2026–2032, supported by increasing contraceptive acceptance, broader reproductive-health engagement, differentiated product formats, commercial and institutional demand, and improving access across physical and digital channels.
  • By route to market, offline commercial retail accounted for an estimated 55% market share in 2026, supported by neighborhood access, established replenishment networks, immediate availability, and broad reach across pharmacies, general trade, convenience stores, supermarkets, hypermarkets, and modern trade.
  • By product type, male/external condoms held an estimated 98% market share in 2026, reflecting consumer familiarity, lower unit prices, straightforward usage, widespread availability, and extensive differentiation through flavors, textures, thinness, lubrication, and extended-pleasure features.
  • The market is concentrated, with the top five companies collectively accounting for an estimated 76% market share in 2026. Competition is centered on brand recognition, product differentiation, pricing and pack architecture, pharmacy and general-trade reach, digital availability, institutional procurement, manufacturing scale, quality certification, consumer engagement, and supply reliability.

India Condom Market Segmentation

  • By Product Type
  • Male/External Condoms
  • Female/Internal Condoms
  • By Material Type
  • Natural Rubber Latex Condoms
  • Non-Latex Condoms
  • By Distribution Channel
  • Offline Commercial Retail
  • Online Commercial Retail
  • Social Marketing and Subsidized Sales
  • Government and Institutional Procurement
  • By Unit Price
  • Up to INR 5 (approx. USD 0.05)
  • INR 6 to 10 (approx. USD 0.06 to 0.10)
  • INR 11 to 15 (approx. USD 0.12 to 0.16)
  • INR 16 to 20 (approx. USD 0.17 to 0.21)
  • Above INR 20 (above approx. USD 0.21)
  • By Pack Size
  • Small Packs (1–3 condoms)
  • Standard Packs (4–12 condoms)
  • Value and Large Packs (13–49 condoms)
  • Bulk Packs (50 condoms and above)
  • By Feature
  • Regular
  • Flavored
  • Textured
  • Thin/Ultra-Thin
  • Extended-Pleasure
  • Others
  • By Region
  • North
  • South
  • West
  • East

Key Players in the India Condom Market

  • Mankind Pharma Limited
  • HLL Lifecare Limited
  • Reckitt Benckiser Group plc
  • TTK Healthcare Limited
  • Godrej Consumer Products Limited
  • Cupid Limited
  • Anondita Medicare Limited
  • Indus Medicare Limited
  • Sirona Hygiene Private Limited
  • Okamoto Industries, Inc.
  • Others

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Need Assistance?

WRITE AN EMAIL

[email protected]
Customization Offered
100% Safe & Secure

Strongest encryption on the website to make your purchase safe and secure